East Village, NY: Vulnerable and Extreme

Exerpts from the introduction to the exhibition catalogue: Seoul Museum of Art presents the exhibition East Village NY: Vulnerable and Extreme, that explores the art of the 1980s East Village, from 13 Dec. 2018 – 6 Feb. 2019. The exhibition invites 26 individual or team of artists and presents 75 artworks. Rather than focusing on individual artist’s great achievements, it attempts to demonstrate the context and the experience of the artists who have led intense lives within the era’s social and political circumstances. […] The works of the East Village artists do not profess a distanced truth appplied only in a particular world, but show diverse yet universe sentiment of art and reality where heterogeneous and marginalised values are discarded. The art scene of the East Village is a singular and historical event beyondrepetition but at the same time, it poits to complex problems that still linger today, all over the world. From political art that strives to reform everyday life to experimental works that are scandalous, the East Village art exudes energy in which we could listen to the voices of the work. Yu Byung Hong Acting Director of Seould Museum of Art Andreas Sterzing: East Village Slide Show (2018) presents 1980s Downtown Manhattan and East Village in 140 slides. The work features: the beginning of Gracie Mansion Gallery, as well as artists – Rodney Alan Greenblat, David Wojnarowicz, Rhonda Zwillinger, Mike Bidlo and others – with their work at the gallery; the studio and portraits of Jean-Michel Basquiat and Keith Haring; prominent galleries such as P.P.O.W., B-Side Gallery and New Math Gallery; graffiti and graffiti artists; shows and performances on the street; Poppo and GoGo Boys performing at the legendary club 8BC and New York Alphabet City street life

Pier 34 NYC 1983-84 slideshow & Portraits of David Wojnarowicz

KW Institute for Contemporary Art is pleased to present the exhibition Photography & Film 1978–1992 that will be the first to solely concentrate on Wojnarowicz’s photographic and filmic work. It will present over 150 works including photographs, test prints, silkscreens, 16mm and super-8 film, and collaborative video works. Afterwards the exhibition will travel to the Morris and Helen Belkin Art Gallery in Vancouver (CA). Curator: Krist Gruijthuijsen The exhibition includes two looped analogue slideshows, as well as two b/w prints of photographs by Andreas Sterzing. Slideshow one contains 32 portraits of David Wojnarowicz, taken in New York between 1983 and 1989. Slideshow two shows 80+80 slides of the project: "Something Possible Everywhere: Pier 34, NYC 1983-84" Slides are projected side by side using two carousel projectors. David Wojnarowicz (1954–1992) came into prominence in the East Village art world of the 1980s, actively embracing all media and forging an expansive range of work both fiercely political and highly personal. Although largely self-taught, he worked as an artist and writer to merge a sophisticated combination of found and discarded material with an uncanny understanding of literary influences. First displayed in rough storefront galleries, his work already gained national prominence at the very moment. Diagnosed with HIV in the late 1980s his work became resolutely and fervently political at a time where the AIDS epidemic was cutting down a generation of artists. From the late 1970s until his death in 1992, Wojnarowicz produced a body of work that was as conceptually rigorous as it was stylistically diverse

Exhibition catalogue: 'Something Possible Everywhere: Pier 34, NYC 1983-84'

'Something Possible Everywhere: Pier 34, NYC 1983-84' Exhibition at 205 Hudson Street Gallery in New York, 30 September to 20 November 201

Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study

<p>Abstract</p> <p>Background</p> <p>The prognosis for patients with advanced FIGO stage III epithelial ovarian cancer remains poor despite the aggressive standard treatment, consisting of maximal cytoreductive surgery and platinum-based chemotherapy. The median time to recurrence is less than 2 years, with a 5-years survival rate of -20-25%. Recurrences of the disease occur mostly intraperitoneally.</p> <p>Ovarian cancer is a radiosensitive tumor, so that the use of whole abdominal radiotherapy (WAR) as a consolidation therapy would appear to be a logical strategy. WAR used to be the standard treatment after surgery before the chemotherapy era; however, it has been almost totally excluded from the treatment of ovarian cancer during the past decade because of its high toxicity. Modern intensity-modulated radiation therapy (IMRT) has the potential of sparing organs at risk like kidneys, liver, and bone marrow while still adequately covering the peritoneal cavity with a homogenous dose.</p> <p>Our previous phase I study showed for the first time the clinical feasibility of intensity-modulated WAR and pointed out promising results concerning treatment tolerance. The current phase-II study succeeds to the phase-I study to further evaluate the toxicity of this new treatment.</p> <p>Methods/design</p> <p>The OVAR-IMRT-02 study is a single-center one arm phase-II trial. Thirty seven patients with optimally debulked ovarian cancer stage FIGO III having a complete remission after chemotherapy will be treated with intensity-modulated WAR as a consolidation therapy.</p> <p>A total dose of 30 Gy in 20 fractions of 1.5 Gy will be applied to the entire peritoneal cavity including the liver surface and the pelvic and para-aortic node regions. Organ at risk are kidneys, liver (except the 1 cm-outer border), heart, vertebral bodies and pelvic bones.</p> <p>Primary endpoint is tolerability; secondary objectives are toxicity, quality of life, progression-free and overall survival.</p> <p>Discussion</p> <p>Intensity-modulated WAR provides a new promising option in the consolidation treatment of ovarian carcinoma in patients with a complete pathologic remission after adjuvant chemotherapy. Further consequent studies will be needed to enable firm conclusions regarding the value of consolidation radiotherapy within the multimodal treatment of advanced ovarian cancer.</p> <p>Trial registration</p> <p>Clinicaltrials.gov: <a href="http://clinicaltrials.gov/ct2/show/NCT01180504">NCT01180504</a></p

Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma

<p>Abstract</p> <p>Background</p> <p>The present study evaluates the outcome of 19 children with rhabdomyosarcoma of the head-and-neck region treated with Intensity Modulated Radiotherapy (IMRT) or Fractionated Stereotactic Radiotherapy (FSRT) between August 1995 and November 2005.</p> <p>Methods</p> <p>We treated 19 children with head-and-neck rhabdomyosarcoma with FSRT (n = 14) or IMRT (n = 5) as a part of multimodal therapy. Median age at the time of radiation therapy was 5 years (range 2–15 years). All children received systemic chemotherapy according to the German Soft Tissue Sarcoma Study protocols.</p> <p>Median size of treatment volume for RT was 93,4 ml. We applied a median total dose of 45 Gy (range 32 Gy – 54 Gy) using a median fractionation of 5 × 1,8 Gy/week (range 1,6 Gy – 1,8 Gy).</p> <p>The median time interval between primary diagnosis and radiation therapy was 5 months (range 3–9 months).</p> <p>Results</p> <p>After RT, the 3- and 5-year survival rate was 94%. The 3- and 5-year actuarial local control rate after RT was 89%.</p> <p>The actuarial freedom of distant metastases rate at 3- and 5-years was 89% for all patients.</p> <p>Radiotherapy was well tolerated in all children and could be completed without interruptions > 4 days. No toxicities >CTC grade 2 were observed. The median follow-up time after RT was 17 months.</p> <p>Conclusion</p> <p>IMRT and FSRT lead to excellent outcome in children with head-and-neck RMS with a low incidence of treatment-related side effects.</p

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol

<p>Abstract</p> <p>Background</p> <p>The prognosis for patients with advanced epithelial ovarian cancer remains poor despite aggressive surgical resection and platinum-based chemotherapy. More than 60% of patients will develop recurrent disease, principally intraperitoneal, and die within 5 years. The use of whole abdominal irradiation (WAI) as consolidation therapy would appear to be a logical strategy given its ability to sterilize small tumour volumes. Despite the clinically proven efficacy of whole abdominal irradiation, the use of radiotherapy in ovarian cancer has profoundly decreased mainly due to high treatment-related toxicity. Modern intensity-modulated radiation therapy (IMRT) could allow to spare kidneys, liver, and bone marrow while still adequately covering the peritoneal cavity with a homogenous dose.</p> <p>Methods/Design</p> <p>The OVAR-IMRT-01 study is a single center pilot trial of a phase I/II study. Patients with advanced ovarian cancer stage FIGO III (R1 or R2< 1 cm) after surgical resection and platinum-based chemotherapy will be treated with whole abdomen irradiation as consolidation therapy using intensity modulated radiation therapy (IMRT) to a total dose of 30 Gy in 1.5 Gy fractions. A total of 8 patients will be included in this trial. For treatment planning bone marrow, kidneys, liver, spinal cord, vertebral bodies and pelvic bones are defined as organs at risk. The planning target volume includes the entire peritoneal cavity plus pelvic and para-aortic node regions.</p> <p>Discussion</p> <p>The primary endpoint of the study is the evaluation of the feasibility of intensity-modulated WAI and the evaluation of the study protocol. Secondary endpoint is evaluation of the toxicity of intensity modulated WAI before continuing with the phase I/II study. The aim is to explore the potential of IMRT as a new method for WAI to decrease the dose to kidneys, liver, bone marrow while covering the peritoneal cavity with a homogenous dose, and to implement whole abdominal intensity-modulated radiotherapy into the adjuvant multimodal treatment concept of advanced ovarian cancer FIGO stage III.</p

Pier 34 NYC 1983-84 - Something Possible Everywhere. A digital slideshow projection.

A digital slideshow installation of my project: "Something Possible Everywhere: Pier 34 New York 1983-84" consisting of 82 images was projected continually at the David Wojnarowicz retrospective exhibition at the Whitney Museum in New York

David Wojnarowicz: History Keeps Me Awake At Night. At Museo Reina Sofia in Madrid from May to September 2019

A looped digital slideshow installation of my project: "Something Possible Everywhere: Pier 34 New York 1983-84" consisting of 82 images was projected continually as part of the David Wojnarowicz retrospective at Museo Reina Sofia in Madrid from 29 May to 30 September 2019

Something Possible Everywhere: Pier 34, NYC 1983-84

Something Possible Everywhere: Pier 34 NYC, 1983–84 is the first exhibition to revisit the extraordinary place and time when David Wojnarowicz and Mike Bidlo, together with friends and peers seized a city-owned pier and filled it with art. This show brings together the work of over 30 artists who were part of the community working on Pier 34. Andreas Sterzing’s remarkable photographs, along with related images by Peter Hujar, Marisela La Grave, and Dirk Rowntree, document how these artists turned the Ward Line shipping terminal at the foot of Canal Street, into a series of makeshift art galleries and studios. Its rooms were filled with art that was often shocking, testing the boundaries of acceptable behaviour and presenting life on the edge. Each creative mind, furthermore, shared ideas and inspiration with another, short-circuiting the hypercompetitive nature of the art market As rumors spread in the spring of 1983 of what was happening on the waterfront, Bidlo and Wojnarowicz released a statement to friends in the press, explaining that their aim was to create an opportunity for everyone “to explore any image in any material on any surface they choose. It was something no gallery would tolerate”. Above all they claimed that Pier 34 forged a community where many artists, for the first time, “experienced fulfillment in terms of contact with the art scene and strangers.” And they claimed there was and is no reason it could not happen somewhere else in the future: “And this is just a start for all of us. We are all responsible for what it currently is and what it will become. This is something possible anywhere there are abandoned buildings. This is something possible everywhere.” Sadly, the building was demolished and almost all of the art made on the pier no longer exists, but the presence of contemporaneous work in the exhibition makes tangible something of the physicality of the waterfront art and its larger aesthetic context

Ressource efficiency - driver for innovations in forming technologies

The requirement to adopt an even more efficient approach to handling existing resources is becoming more and more urgent in politics, economy and research. At the same time, this raises the question of what options are available to companies in the manufacturing industries, the OEMs and, in particular, supplier companies of the automotive industry as regards reducing costs as well as minimising their consumption of resources and reducing emissions by using more efficient technologies and production systems. The presentation will discuss strategic approaches to meet these future challenges. In this context, it will also give an overview about the core competencies of Fraunhofer in the field of resource-efficient forming processes. The contribution will present strategic approaches to meet these future challenges. Strategies will be discussed to improve efficiency Ø in product operation à reduction of energy consumption and emissions - lightweight design (e. g. materials, design, processes) - tailored material / product properties (e. g. modification of materials based on forming technologies) as well as Ø in product manufacturing à reduction of resource use - increase of process reliability (e. g. process monitoring and control) - process substitution / combination (e. g. substitution of machining by forming processes) - highly efficient tool making processes (e. g. innovative machine concepts) Considering these, selected projects will be presented which will underline Fraunhofer's focus on industrial applications